Literature DB >> 15745989

ACE inhibition in stable coronary artery disease.

Salim Yusuf, Janice Pogue.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15745989     DOI: 10.1056/NEJM200503033520919

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  ACE inhibition in secondary prevention: are the results controversial?

Authors:  Erik B Friedrich; Koon K Teo; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2006-01-16       Impact factor: 5.460

2.  The origin of modern terrestrial life.

Authors:  Patrick Forterre; Simonetta Gribaldo
Journal:  HFSP J       Date:  2007-07-25

Review 3.  [Secondary prevention after myocardial infarction].

Authors:  J E Pflumm; T Pomykaj; M P Heintzen
Journal:  Internist (Berl)       Date:  2008-09       Impact factor: 0.743

4.  Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure.

Authors:  Emmanuel Sorbets; Julien Labreuche; Tabassome Simon; Laurent Delorme; Nicolas Danchin; Pierre Amarenco; Shinya Goto; Christophe Meune; Kim A Eagle; Deepak L Bhatt; Philippe Gabriel Steg
Journal:  Eur Heart J       Date:  2014-03-09       Impact factor: 29.983

Review 5.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

6.  Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease.

Authors:  Torsten Doenst; John G F Cleland; Jean L Rouleau; Lilin She; Stanislaw Wos; E Magnus Ohman; Maria Krzeminska-Pakula; Balram Airan; Robert H Jones; Matthias Siepe; George Sopko; Eric J Velazquez; Normand Racine; Lars Gullestad; Jose Luis Filgueira; Kerry L Lee
Journal:  Circ Heart Fail       Date:  2013-03-20       Impact factor: 8.790

7.  The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.

Authors:  Ae-Young Her; Byoung Geol Choi; Seung-Woon Rha; Yong Hoon Kim; Cheol Ung Choi; Myung Ho Jeong
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.